Reports have implicated prorenin-mediated PRR functions in various tissues in the development of metabolic syndrome features, including diabetes, obesity, and obesity-related hypertension [11,12,13]. The gene discussed is ATP6AP2; the disease is obesity due to melanocortin 4 receptor deficiency.